Gilead Sciences (NASDAQ: GILD) and the U.S. government have settled a billion-dollar patent dispute over Gilead’s HIV prevention drugs Truvada […]
Gilead Sciences, US Government Settle Patent Case Over HIV Prevention Drugs Read More »
On Thursday, Gilead Sciences (NASDAQ: GILD) said it has appointed Sanofi’s (NASDAQ: SNY) Dietmar Berger as its chief medical officer,
Gilead Appoints Sanofi Official Dietmar Berger as Next Chief Medical Officer Read More »
Gilead Sciences (NASDAQ: GILD) reported third-quarter financial results that handily beat Wall Street expectations on Wednesday as sales climbed 7%,
Gilead Sciences (NASDAQ: GILD) Stock Jumps on Upbeat Q3 Results, Full-Year Outlook Read More »
Shares of Gilead Sciences (NASDAQ: GILD) plunged by almost 10% on Monday following the disappointing outcome of a lung cancer
Gilead Sciences (NASDAQ: GILD) Stock Slumps as Lung Cancer Drug Trial Results Disappoint Read More »
Copyright © 2025 abbonews.com
